Skip to content

Multimodal and Unimodal Analgesia in Cholecystectomy

Comparison Between Multimodal and Unimodal Analgesia in Cholecystectomy

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05547659
Enrollment
95
Registered
2022-09-21
Start date
2019-01-01
Completion date
2020-12-01
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compare Unimodal and Multimodal Analgesics

Brief summary

Many surgical procedures are accompanied by postoperative pain with severity moderate, severe or extreme and insufficient postoperative pain control may cause risk of post-surgical complications and risk of chronic post-surgical pain The targets of preoperative pain management are to relieve patient suffering, reduce length of hospital stay and achieve early mobilization after surgery, decreasing opioid consumption and its side effects that are constipation, nausea, vomiting, dizziness, respiratory depression which is the most feared complication being life-threatening and some less common side effects as sedation

Interventions

DRUGPregabalin 150mg

Pregabalin 150mg preoperative in unimodal group Pregabalin 150mg preoperative in multi-modal group

DRUGAcetaminophen 1 G Oral Tablet

Acetaminophen 1 G Oral Tablet preoperative in multi-modal group

DRUGCelecoxib 400Mg Oral Capsule

Celecoxib 400Mg Oral Capsule preoperative in multi-modal group

Sponsors

Beni-Suef University
CollaboratorOTHER
October 6 University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing laparoscopic cholecystectomy * Patients older than 18 years old

Exclusion criteria

* Renal or hepatic or cardiac impairment patients * Patients with chronic pain history * Allergic patients after taking aspirin or other NSAIDs * patients with active gastrointestinal bleeding, ulcer and inflammatory bowel diseases or cerebrovascular bleeding

Design outcomes

Primary

MeasureTime frameDescription
Postoperative visual analogue scale (VAS)24 hour postoperativeThe visual analog scale (VAS) is a simple and often used method for evaluating variations in pain intensity.
Amount of post operative Needed opioid analgesia24 hour postoperativeampules of opioid analgesia needed after operation

Secondary

MeasureTime frameDescription
Type and amount of prescribed post operative non opioid analgesia24 hour postoperativeType and amount of prescribed post operative non opioid analgesia

Other

MeasureTime frameDescription
Reported opioid side effects24 hour postoperativeSide effects reported after opioid administration eg. nausea, vomiting, respiratory depression etc..

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026